Lv1
70 积分 2025-07-10 加入
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
1个月前
已完结
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial
5个月前
已完结
HIIT may ameliorate inter-organ crosstalk between liver and hypothalamus of HFD-induced MAFLD rats; A two-phase study to investigate the effect of exercise intensity as a stressor
5个月前
已完结
Liver-specific actions of GH and IGF1 that protect against MASLD
6个月前
已完结
NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease
8个月前
已完结
The role of hypothalamus in the pathophysiological process of MASLD and advances in drug discovery
10个月前
已完结
Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults
1年前
已完结
Prevalence of subclinical hypothyroidism and longitudinal thyroid stimulating hormone changes in youth with metabolic dysfunction-associated steatotic liver disease: an observational study
1年前
已完结
皖公网安备34019202002308
